A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40200-020-00619-9.pdf
Reference64 articles.
1. Ginsberg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr. 2009;4(2):113–9.
2. International Diabetes Federation (IDF). IDF Diabetes Atlas - 8th Edition. 2017. https://diabetesatlas.org/resources/2017-atlas.html.
3. Care D. Standards of Medical Care in Diabetesd 2019. Diabetes Care. 2019;42:S81.
4. Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3.
5. DeFronzo RA. From the triumvirate to the „ominous octet”: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009; 58(4): 773–795.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liraglutide for the Treatment of Weight Regain After Bariatric Surgery: A Systematic Review and Meta-analysis;Obesity Surgery;2024-07-10
2. Clinical Pharmacokinetics of Semaglutide: A Systematic Review;Drug Design, Development and Therapy;2024-06
3. The Glucagon-Like Peptide-1 Analogues therapy in the non-diabetic patients;Prospects in Pharmaceutical Sciences;2023-03-13
4. Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment;Current Issues in Molecular Biology;2023-02-06
5. Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review);Experimental and Therapeutic Medicine;2021-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3